Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Curr Mol Pharmacol ; 13(1): 7-16, 2020.
Article in English | MEDLINE | ID: mdl-31333144

ABSTRACT

BACKGROUND: Chlorogenic acid (CGA) is a quinic acid conjugate of caffeic acid. It is an ester formed between caffeic acid and the 3-hydroxyl of L-quinic acid. This polyphenol is naturally present in substantial amount in the green coffee beans. Minor quantities of CGA are also reported in apples, eggplant, blueberries, tomatoes, strawberries and potatoes. CGA is reported to be beneficial in hypertension, hyperglycemia, antimicrobial, antitumor, memory enhancer, weight management etc. Further, it is also reported to have anticancer, antioxidant and anti-inflammatory activities. Since the last decade, CGA drew public attention for its widely recommended use as a medicine or natural food additive supplement for the management of obesity. OBJECTIVE: The current review explores the medicinal promises of CGA and emphasizes on its antiobese property as reported by various scientific reports and publication. CONCLUSION: CGA shows promises as an antioxidant, glycemic control agent, anti-hypertensive, antiinflammatory, antimicrobial, neuro-protective and anti-obesity agent. It primarily activates the AMPactivated protein kinase, inhibits 3-hydroxy 3-methylglutaryl coenzyme-A reductase and strengthens the activity of carnitine palmitoyltransferase to control the obesity.


Subject(s)
Anti-Obesity Agents/therapeutic use , Chlorogenic Acid/therapeutic use , Obesity/drug therapy , Adenylate Kinase/drug effects , Animals , Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Anti-Obesity Agents/pharmacology , Antihypertensive Agents/pharmacology , Antihypertensive Agents/therapeutic use , Antioxidants/pharmacology , Antioxidants/therapeutic use , Carnitine O-Palmitoyltransferase/drug effects , Chlorogenic Acid/isolation & purification , Chlorogenic Acid/pharmacology , Coffee/chemistry , Drug Evaluation, Preclinical , Enzyme Activation/drug effects , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hypolipidemic Agents/pharmacology , Hypolipidemic Agents/therapeutic use , Lipid Metabolism/drug effects , Mice , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , PPAR alpha/agonists
SELECTION OF CITATIONS
SEARCH DETAIL